nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Gefitinib—lung cancer	0.0539	0.0951	CbGbCtD
Bicalutamide—CYP2C19—Teniposide—lung cancer	0.0522	0.0922	CbGbCtD
Bicalutamide—CYP2C9—Gefitinib—lung cancer	0.0448	0.079	CbGbCtD
Bicalutamide—CYP2C9—Teniposide—lung cancer	0.0434	0.0766	CbGbCtD
Bicalutamide—CYP2D6—Gefitinib—lung cancer	0.0409	0.0723	CbGbCtD
Bicalutamide—CYP2D6—Vinorelbine—lung cancer	0.0315	0.0557	CbGbCtD
Bicalutamide—CYP3A4—Topotecan—lung cancer	0.0285	0.0503	CbGbCtD
Bicalutamide—CYP3A4—Gefitinib—lung cancer	0.026	0.046	CbGbCtD
Bicalutamide—CYP3A4—Teniposide—lung cancer	0.0252	0.0446	CbGbCtD
Bicalutamide—CYP2C9—Paclitaxel—lung cancer	0.0242	0.0428	CbGbCtD
Bicalutamide—CYP2D6—Erlotinib—lung cancer	0.0242	0.0427	CbGbCtD
Bicalutamide—CYP3A4—Vinorelbine—lung cancer	0.0201	0.0354	CbGbCtD
Bicalutamide—CYP2C9—Cisplatin—lung cancer	0.0195	0.0344	CbGbCtD
Bicalutamide—CYP2D6—Vinblastine—lung cancer	0.0194	0.0343	CbGbCtD
Bicalutamide—CYP3A4—Crizotinib—lung cancer	0.016	0.0282	CbGbCtD
Bicalutamide—CYP3A4—Erlotinib—lung cancer	0.0154	0.0272	CbGbCtD
Bicalutamide—CYP3A4—Paclitaxel—lung cancer	0.0141	0.0249	CbGbCtD
Bicalutamide—CYP3A4—Irinotecan—lung cancer	0.0139	0.0245	CbGbCtD
Bicalutamide—CYP3A4—Vinblastine—lung cancer	0.0124	0.0218	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—lung cancer	0.0119	0.0211	CbGbCtD
Bicalutamide—CYP3A4—Etoposide—lung cancer	0.0111	0.0197	CbGbCtD
Bicalutamide—CYP3A4—Docetaxel—lung cancer	0.0102	0.018	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—lung cancer	0.00759	0.0134	CbGbCtD
Bicalutamide—Enzalutamide—ALB—lung cancer	0.0014	0.512	CrCbGaD
Bicalutamide—Enzalutamide—ABCB1—lung cancer	0.00134	0.488	CrCbGaD
Bicalutamide—Cough—Docetaxel—lung cancer	0.000107	0.000332	CcSEcCtD
Bicalutamide—Angina pectoris—Doxorubicin—lung cancer	0.000107	0.000332	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Methotrexate—lung cancer	0.000107	0.000332	CcSEcCtD
Bicalutamide—Insomnia—Paclitaxel—lung cancer	0.000106	0.000331	CcSEcCtD
Bicalutamide—Epistaxis—Methotrexate—lung cancer	0.000106	0.000331	CcSEcCtD
Bicalutamide—Hypersensitivity—Irinotecan—lung cancer	0.000106	0.000331	CcSEcCtD
Bicalutamide—Paraesthesia—Paclitaxel—lung cancer	0.000106	0.000329	CcSEcCtD
Bicalutamide—Hypertension—Docetaxel—lung cancer	0.000105	0.000329	CcSEcCtD
Bicalutamide—Bronchitis—Doxorubicin—lung cancer	0.000105	0.000328	CcSEcCtD
Bicalutamide—Dyspnoea—Paclitaxel—lung cancer	0.000105	0.000327	CcSEcCtD
Bicalutamide—Somnolence—Paclitaxel—lung cancer	0.000105	0.000326	CcSEcCtD
Bicalutamide—Decreased appetite—Etoposide—lung cancer	0.000104	0.000325	CcSEcCtD
Bicalutamide—Chest pain—Docetaxel—lung cancer	0.000104	0.000324	CcSEcCtD
Bicalutamide—Myalgia—Docetaxel—lung cancer	0.000104	0.000324	CcSEcCtD
Bicalutamide—Nausea—Vinorelbine—lung cancer	0.000104	0.000324	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Etoposide—lung cancer	0.000104	0.000323	CcSEcCtD
Bicalutamide—Dyspepsia—Paclitaxel—lung cancer	0.000104	0.000323	CcSEcCtD
Bicalutamide—Body temperature increased—Cisplatin—lung cancer	0.000104	0.000322	CcSEcCtD
Bicalutamide—Asthenia—Irinotecan—lung cancer	0.000103	0.000322	CcSEcCtD
Bicalutamide—Fatigue—Etoposide—lung cancer	0.000103	0.000322	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000103	0.000322	CcSEcCtD
Bicalutamide—Pain—Etoposide—lung cancer	0.000103	0.00032	CcSEcCtD
Bicalutamide—Constipation—Etoposide—lung cancer	0.000103	0.00032	CcSEcCtD
Bicalutamide—Neutropenia—Doxorubicin—lung cancer	0.000102	0.000319	CcSEcCtD
Bicalutamide—Dysuria—Doxorubicin—lung cancer	0.000102	0.000319	CcSEcCtD
Bicalutamide—Decreased appetite—Paclitaxel—lung cancer	0.000102	0.000319	CcSEcCtD
Bicalutamide—Dry mouth—Docetaxel—lung cancer	0.000102	0.000317	CcSEcCtD
Bicalutamide—Haemoglobin—Methotrexate—lung cancer	0.000102	0.000317	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000102	0.000316	CcSEcCtD
Bicalutamide—Fatigue—Paclitaxel—lung cancer	0.000101	0.000316	CcSEcCtD
Bicalutamide—Haemorrhage—Methotrexate—lung cancer	0.000101	0.000315	CcSEcCtD
Bicalutamide—Pollakiuria—Doxorubicin—lung cancer	0.000101	0.000315	CcSEcCtD
Bicalutamide—Asthenia—Gemcitabine—lung cancer	0.000101	0.000314	CcSEcCtD
Bicalutamide—Pain—Paclitaxel—lung cancer	0.000101	0.000313	CcSEcCtD
Bicalutamide—Constipation—Paclitaxel—lung cancer	0.000101	0.000313	CcSEcCtD
Bicalutamide—Confusional state—Docetaxel—lung cancer	0.000101	0.000313	CcSEcCtD
Bicalutamide—Pharyngitis—Methotrexate—lung cancer	0.0001	0.000313	CcSEcCtD
Bicalutamide—Urinary tract disorder—Methotrexate—lung cancer	9.99e-05	0.000311	CcSEcCtD
Bicalutamide—Oedema—Docetaxel—lung cancer	9.97e-05	0.000311	CcSEcCtD
Bicalutamide—Weight increased—Doxorubicin—lung cancer	9.96e-05	0.00031	CcSEcCtD
Bicalutamide—Pruritus—Gemcitabine—lung cancer	9.94e-05	0.00031	CcSEcCtD
Bicalutamide—Urethral disorder—Methotrexate—lung cancer	9.92e-05	0.000309	CcSEcCtD
Bicalutamide—Infection—Docetaxel—lung cancer	9.91e-05	0.000309	CcSEcCtD
Bicalutamide—Weight decreased—Doxorubicin—lung cancer	9.9e-05	0.000308	CcSEcCtD
Bicalutamide—Feeling abnormal—Etoposide—lung cancer	9.89e-05	0.000308	CcSEcCtD
Bicalutamide—Hyperglycaemia—Doxorubicin—lung cancer	9.87e-05	0.000307	CcSEcCtD
Bicalutamide—Diarrhoea—Irinotecan—lung cancer	9.87e-05	0.000307	CcSEcCtD
Bicalutamide—Pneumonia—Doxorubicin—lung cancer	9.81e-05	0.000306	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Etoposide—lung cancer	9.81e-05	0.000306	CcSEcCtD
Bicalutamide—Shock—Docetaxel—lung cancer	9.81e-05	0.000306	CcSEcCtD
Bicalutamide—Nervous system disorder—Docetaxel—lung cancer	9.78e-05	0.000305	CcSEcCtD
Bicalutamide—Thrombocytopenia—Docetaxel—lung cancer	9.76e-05	0.000304	CcSEcCtD
Bicalutamide—Visual impairment—Methotrexate—lung cancer	9.75e-05	0.000304	CcSEcCtD
Bicalutamide—Feeling abnormal—Paclitaxel—lung cancer	9.69e-05	0.000302	CcSEcCtD
Bicalutamide—Skin disorder—Docetaxel—lung cancer	9.69e-05	0.000302	CcSEcCtD
Bicalutamide—Hypersensitivity—Cisplatin—lung cancer	9.65e-05	0.000301	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Paclitaxel—lung cancer	9.62e-05	0.0003	CcSEcCtD
Bicalutamide—Diarrhoea—Gemcitabine—lung cancer	9.61e-05	0.000299	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Doxorubicin—lung cancer	9.56e-05	0.000298	CcSEcCtD
Bicalutamide—Dizziness—Irinotecan—lung cancer	9.54e-05	0.000297	CcSEcCtD
Bicalutamide—Urticaria—Etoposide—lung cancer	9.53e-05	0.000297	CcSEcCtD
Bicalutamide—Jaundice—Doxorubicin—lung cancer	9.51e-05	0.000296	CcSEcCtD
Bicalutamide—Anorexia—Docetaxel—lung cancer	9.5e-05	0.000296	CcSEcCtD
Bicalutamide—Abdominal pain—Etoposide—lung cancer	9.49e-05	0.000295	CcSEcCtD
Bicalutamide—Body temperature increased—Etoposide—lung cancer	9.49e-05	0.000295	CcSEcCtD
Bicalutamide—Urinary tract infection—Doxorubicin—lung cancer	9.48e-05	0.000295	CcSEcCtD
Bicalutamide—Conjunctivitis—Doxorubicin—lung cancer	9.48e-05	0.000295	CcSEcCtD
Bicalutamide—Asthenia—Cisplatin—lung cancer	9.4e-05	0.000293	CcSEcCtD
Bicalutamide—Cardiac disorder—Methotrexate—lung cancer	9.39e-05	0.000292	CcSEcCtD
Bicalutamide—Sweating—Doxorubicin—lung cancer	9.35e-05	0.000291	CcSEcCtD
Bicalutamide—Urticaria—Paclitaxel—lung cancer	9.35e-05	0.000291	CcSEcCtD
Bicalutamide—Haematuria—Doxorubicin—lung cancer	9.3e-05	0.00029	CcSEcCtD
Bicalutamide—Abdominal pain—Paclitaxel—lung cancer	9.3e-05	0.00029	CcSEcCtD
Bicalutamide—Body temperature increased—Paclitaxel—lung cancer	9.3e-05	0.00029	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Doxorubicin—lung cancer	9.23e-05	0.000287	CcSEcCtD
Bicalutamide—Epistaxis—Doxorubicin—lung cancer	9.2e-05	0.000287	CcSEcCtD
Bicalutamide—Angiopathy—Methotrexate—lung cancer	9.18e-05	0.000286	CcSEcCtD
Bicalutamide—Vomiting—Irinotecan—lung cancer	9.17e-05	0.000286	CcSEcCtD
Bicalutamide—Sinusitis—Doxorubicin—lung cancer	9.15e-05	0.000285	CcSEcCtD
Bicalutamide—Immune system disorder—Methotrexate—lung cancer	9.14e-05	0.000285	CcSEcCtD
Bicalutamide—Mediastinal disorder—Methotrexate—lung cancer	9.12e-05	0.000284	CcSEcCtD
Bicalutamide—Rash—Irinotecan—lung cancer	9.1e-05	0.000283	CcSEcCtD
Bicalutamide—Dermatitis—Irinotecan—lung cancer	9.09e-05	0.000283	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Docetaxel—lung cancer	9.08e-05	0.000283	CcSEcCtD
Bicalutamide—Chills—Methotrexate—lung cancer	9.08e-05	0.000283	CcSEcCtD
Bicalutamide—Headache—Irinotecan—lung cancer	9.04e-05	0.000281	CcSEcCtD
Bicalutamide—Insomnia—Docetaxel—lung cancer	9.02e-05	0.000281	CcSEcCtD
Bicalutamide—Diarrhoea—Cisplatin—lung cancer	8.96e-05	0.000279	CcSEcCtD
Bicalutamide—Paraesthesia—Docetaxel—lung cancer	8.95e-05	0.000279	CcSEcCtD
Bicalutamide—Alopecia—Methotrexate—lung cancer	8.94e-05	0.000278	CcSEcCtD
Bicalutamide—Vomiting—Gemcitabine—lung cancer	8.93e-05	0.000278	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—lung cancer	8.92e-05	0.000278	CcSEcCtD
Bicalutamide—Dyspnoea—Docetaxel—lung cancer	8.89e-05	0.000277	CcSEcCtD
Bicalutamide—Somnolence—Docetaxel—lung cancer	8.86e-05	0.000276	CcSEcCtD
Bicalutamide—Mental disorder—Methotrexate—lung cancer	8.86e-05	0.000276	CcSEcCtD
Bicalutamide—Rash—Gemcitabine—lung cancer	8.86e-05	0.000276	CcSEcCtD
Bicalutamide—Dermatitis—Gemcitabine—lung cancer	8.85e-05	0.000276	CcSEcCtD
Bicalutamide—Hypersensitivity—Etoposide—lung cancer	8.84e-05	0.000275	CcSEcCtD
Bicalutamide—Malnutrition—Methotrexate—lung cancer	8.81e-05	0.000274	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—lung cancer	8.8e-05	0.000274	CcSEcCtD
Bicalutamide—Headache—Gemcitabine—lung cancer	8.8e-05	0.000274	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—lung cancer	8.78e-05	0.000274	CcSEcCtD
Bicalutamide—Dyspepsia—Docetaxel—lung cancer	8.78e-05	0.000273	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—lung cancer	8.76e-05	0.000273	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—lung cancer	8.69e-05	0.000271	CcSEcCtD
Bicalutamide—Decreased appetite—Docetaxel—lung cancer	8.67e-05	0.00027	CcSEcCtD
Bicalutamide—Hypersensitivity—Paclitaxel—lung cancer	8.67e-05	0.00027	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—lung cancer	8.65e-05	0.000269	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—lung cancer	8.63e-05	0.000269	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Docetaxel—lung cancer	8.61e-05	0.000268	CcSEcCtD
Bicalutamide—Asthenia—Etoposide—lung cancer	8.61e-05	0.000268	CcSEcCtD
Bicalutamide—Fatigue—Docetaxel—lung cancer	8.6e-05	0.000268	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—lung cancer	8.59e-05	0.000267	CcSEcCtD
Bicalutamide—Nausea—Irinotecan—lung cancer	8.57e-05	0.000267	CcSEcCtD
Bicalutamide—Pain—Docetaxel—lung cancer	8.53e-05	0.000266	CcSEcCtD
Bicalutamide—Constipation—Docetaxel—lung cancer	8.53e-05	0.000266	CcSEcCtD
Bicalutamide—Back pain—Methotrexate—lung cancer	8.52e-05	0.000265	CcSEcCtD
Bicalutamide—Pruritus—Etoposide—lung cancer	8.49e-05	0.000264	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—lung cancer	8.44e-05	0.000263	CcSEcCtD
Bicalutamide—Asthenia—Paclitaxel—lung cancer	8.44e-05	0.000263	CcSEcCtD
Bicalutamide—Nausea—Gemcitabine—lung cancer	8.35e-05	0.00026	CcSEcCtD
Bicalutamide—Vomiting—Cisplatin—lung cancer	8.33e-05	0.000259	CcSEcCtD
Bicalutamide—Pruritus—Paclitaxel—lung cancer	8.32e-05	0.000259	CcSEcCtD
Bicalutamide—Rash—Cisplatin—lung cancer	8.26e-05	0.000257	CcSEcCtD
Bicalutamide—Dermatitis—Cisplatin—lung cancer	8.25e-05	0.000257	CcSEcCtD
Bicalutamide—Feeling abnormal—Docetaxel—lung cancer	8.22e-05	0.000256	CcSEcCtD
Bicalutamide—Diarrhoea—Etoposide—lung cancer	8.21e-05	0.000256	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Docetaxel—lung cancer	8.15e-05	0.000254	CcSEcCtD
Bicalutamide—Anaemia—Methotrexate—lung cancer	8.14e-05	0.000254	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—lung cancer	8.13e-05	0.000253	CcSEcCtD
Bicalutamide—Diarrhoea—Paclitaxel—lung cancer	8.05e-05	0.000251	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—lung cancer	7.95e-05	0.000248	CcSEcCtD
Bicalutamide—Dizziness—Etoposide—lung cancer	7.93e-05	0.000247	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—lung cancer	7.91e-05	0.000246	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—lung cancer	7.89e-05	0.000246	CcSEcCtD
Bicalutamide—Abdominal pain—Docetaxel—lung cancer	7.88e-05	0.000246	CcSEcCtD
Bicalutamide—Body temperature increased—Docetaxel—lung cancer	7.88e-05	0.000246	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—lung cancer	7.86e-05	0.000245	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—lung cancer	7.83e-05	0.000244	CcSEcCtD
Bicalutamide—Dizziness—Paclitaxel—lung cancer	7.78e-05	0.000242	CcSEcCtD
Bicalutamide—Nausea—Cisplatin—lung cancer	7.78e-05	0.000242	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—lung cancer	7.74e-05	0.000241	CcSEcCtD
Bicalutamide—Cough—Methotrexate—lung cancer	7.68e-05	0.000239	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—lung cancer	7.67e-05	0.000239	CcSEcCtD
Bicalutamide—Vomiting—Etoposide—lung cancer	7.63e-05	0.000238	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—lung cancer	7.63e-05	0.000238	CcSEcCtD
Bicalutamide—Rash—Etoposide—lung cancer	7.57e-05	0.000236	CcSEcCtD
Bicalutamide—Dermatitis—Etoposide—lung cancer	7.56e-05	0.000235	CcSEcCtD
Bicalutamide—Headache—Etoposide—lung cancer	7.52e-05	0.000234	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—lung cancer	7.51e-05	0.000234	CcSEcCtD
Bicalutamide—Chest pain—Methotrexate—lung cancer	7.5e-05	0.000234	CcSEcCtD
Bicalutamide—Myalgia—Methotrexate—lung cancer	7.5e-05	0.000234	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—lung cancer	7.48e-05	0.000233	CcSEcCtD
Bicalutamide—Vomiting—Paclitaxel—lung cancer	7.48e-05	0.000233	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.45e-05	0.000232	CcSEcCtD
Bicalutamide—Rash—Paclitaxel—lung cancer	7.42e-05	0.000231	CcSEcCtD
Bicalutamide—Dermatitis—Paclitaxel—lung cancer	7.41e-05	0.000231	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—lung cancer	7.41e-05	0.000231	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—lung cancer	7.38e-05	0.00023	CcSEcCtD
Bicalutamide—Headache—Paclitaxel—lung cancer	7.37e-05	0.00023	CcSEcCtD
Bicalutamide—Hypersensitivity—Docetaxel—lung cancer	7.35e-05	0.000229	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—lung cancer	7.33e-05	0.000228	CcSEcCtD
Bicalutamide—Confusional state—Methotrexate—lung cancer	7.25e-05	0.000226	CcSEcCtD
Bicalutamide—Asthenia—Docetaxel—lung cancer	7.15e-05	0.000223	CcSEcCtD
Bicalutamide—Infection—Methotrexate—lung cancer	7.14e-05	0.000222	CcSEcCtD
Bicalutamide—Nausea—Etoposide—lung cancer	7.13e-05	0.000222	CcSEcCtD
Bicalutamide—Pruritus—Docetaxel—lung cancer	7.05e-05	0.00022	CcSEcCtD
Bicalutamide—Nervous system disorder—Methotrexate—lung cancer	7.05e-05	0.00022	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—lung cancer	7.05e-05	0.00022	CcSEcCtD
Bicalutamide—Thrombocytopenia—Methotrexate—lung cancer	7.04e-05	0.000219	CcSEcCtD
Bicalutamide—Nausea—Paclitaxel—lung cancer	6.99e-05	0.000218	CcSEcCtD
Bicalutamide—Skin disorder—Methotrexate—lung cancer	6.98e-05	0.000217	CcSEcCtD
Bicalutamide—Hyperhidrosis—Methotrexate—lung cancer	6.95e-05	0.000216	CcSEcCtD
Bicalutamide—Anorexia—Methotrexate—lung cancer	6.85e-05	0.000213	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—lung cancer	6.84e-05	0.000213	CcSEcCtD
Bicalutamide—Diarrhoea—Docetaxel—lung cancer	6.82e-05	0.000213	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—lung cancer	6.7e-05	0.000209	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—lung cancer	6.65e-05	0.000207	CcSEcCtD
Bicalutamide—Dizziness—Docetaxel—lung cancer	6.59e-05	0.000205	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—lung cancer	6.58e-05	0.000205	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Methotrexate—lung cancer	6.55e-05	0.000204	CcSEcCtD
Bicalutamide—Insomnia—Methotrexate—lung cancer	6.5e-05	0.000202	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—lung cancer	6.49e-05	0.000202	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—lung cancer	6.49e-05	0.000202	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—lung cancer	6.47e-05	0.000202	CcSEcCtD
Bicalutamide—Paraesthesia—Methotrexate—lung cancer	6.45e-05	0.000201	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.45e-05	0.000201	CcSEcCtD
Bicalutamide—Dyspnoea—Methotrexate—lung cancer	6.41e-05	0.0002	CcSEcCtD
Bicalutamide—Somnolence—Methotrexate—lung cancer	6.39e-05	0.000199	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—lung cancer	6.35e-05	0.000198	CcSEcCtD
Bicalutamide—Vomiting—Docetaxel—lung cancer	6.34e-05	0.000197	CcSEcCtD
Bicalutamide—Dyspepsia—Methotrexate—lung cancer	6.33e-05	0.000197	CcSEcCtD
Bicalutamide—Rash—Docetaxel—lung cancer	6.29e-05	0.000196	CcSEcCtD
Bicalutamide—Dermatitis—Docetaxel—lung cancer	6.28e-05	0.000196	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—lung cancer	6.27e-05	0.000195	CcSEcCtD
Bicalutamide—Decreased appetite—Methotrexate—lung cancer	6.25e-05	0.000195	CcSEcCtD
Bicalutamide—Headache—Docetaxel—lung cancer	6.25e-05	0.000195	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—lung cancer	6.22e-05	0.000194	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Methotrexate—lung cancer	6.2e-05	0.000193	CcSEcCtD
Bicalutamide—Fatigue—Methotrexate—lung cancer	6.2e-05	0.000193	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—lung cancer	6.18e-05	0.000193	CcSEcCtD
Bicalutamide—Pain—Methotrexate—lung cancer	6.15e-05	0.000191	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—lung cancer	6.12e-05	0.000191	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—lung cancer	6.1e-05	0.00019	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—lung cancer	6.09e-05	0.00019	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—lung cancer	6.04e-05	0.000188	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—lung cancer	6.02e-05	0.000187	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—lung cancer	5.93e-05	0.000185	CcSEcCtD
Bicalutamide—Nausea—Docetaxel—lung cancer	5.92e-05	0.000184	CcSEcCtD
Bicalutamide—Feeling abnormal—Methotrexate—lung cancer	5.92e-05	0.000184	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Methotrexate—lung cancer	5.88e-05	0.000183	CcSEcCtD
Bicalutamide—Urticaria—Methotrexate—lung cancer	5.71e-05	0.000178	CcSEcCtD
Bicalutamide—Abdominal pain—Methotrexate—lung cancer	5.68e-05	0.000177	CcSEcCtD
Bicalutamide—Body temperature increased—Methotrexate—lung cancer	5.68e-05	0.000177	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.67e-05	0.000177	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—lung cancer	5.63e-05	0.000175	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—lung cancer	5.59e-05	0.000174	CcSEcCtD
Bicalutamide—Dyspnoea—Doxorubicin—lung cancer	5.55e-05	0.000173	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—lung cancer	5.53e-05	0.000172	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—lung cancer	5.48e-05	0.000171	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—lung cancer	5.41e-05	0.000168	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—lung cancer	5.37e-05	0.000167	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—lung cancer	5.37e-05	0.000167	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—lung cancer	5.32e-05	0.000166	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—lung cancer	5.32e-05	0.000166	CcSEcCtD
Bicalutamide—Hypersensitivity—Methotrexate—lung cancer	5.3e-05	0.000165	CcSEcCtD
Bicalutamide—Asthenia—Methotrexate—lung cancer	5.16e-05	0.000161	CcSEcCtD
Bicalutamide—Feeling abnormal—Doxorubicin—lung cancer	5.13e-05	0.00016	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Doxorubicin—lung cancer	5.09e-05	0.000159	CcSEcCtD
Bicalutamide—Pruritus—Methotrexate—lung cancer	5.08e-05	0.000158	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—lung cancer	4.94e-05	0.000154	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—lung cancer	4.92e-05	0.000153	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—lung cancer	4.92e-05	0.000153	CcSEcCtD
Bicalutamide—Diarrhoea—Methotrexate—lung cancer	4.92e-05	0.000153	CcSEcCtD
Bicalutamide—Dizziness—Methotrexate—lung cancer	4.75e-05	0.000148	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—lung cancer	4.58e-05	0.000143	CcSEcCtD
Bicalutamide—Vomiting—Methotrexate—lung cancer	4.57e-05	0.000142	CcSEcCtD
Bicalutamide—Rash—Methotrexate—lung cancer	4.53e-05	0.000141	CcSEcCtD
Bicalutamide—Dermatitis—Methotrexate—lung cancer	4.53e-05	0.000141	CcSEcCtD
Bicalutamide—Headache—Methotrexate—lung cancer	4.5e-05	0.00014	CcSEcCtD
Bicalutamide—Asthenia—Doxorubicin—lung cancer	4.46e-05	0.000139	CcSEcCtD
Bicalutamide—Pruritus—Doxorubicin—lung cancer	4.4e-05	0.000137	CcSEcCtD
Bicalutamide—Nausea—Methotrexate—lung cancer	4.27e-05	0.000133	CcSEcCtD
Bicalutamide—Diarrhoea—Doxorubicin—lung cancer	4.26e-05	0.000133	CcSEcCtD
Bicalutamide—Dizziness—Doxorubicin—lung cancer	4.12e-05	0.000128	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—PLBD1—lung cancer	3.99e-05	0.000364	CbGpPWpGaD
Bicalutamide—Vomiting—Doxorubicin—lung cancer	3.96e-05	0.000123	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.94e-05	0.000359	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.93e-05	0.000358	CbGpPWpGaD
Bicalutamide—Rash—Doxorubicin—lung cancer	3.92e-05	0.000122	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—lung cancer	3.92e-05	0.000122	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—lung cancer	3.9e-05	0.000121	CcSEcCtD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.8e-05	0.000346	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.75e-05	0.000342	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.75e-05	0.000341	CbGpPWpGaD
Bicalutamide—Nausea—Doxorubicin—lung cancer	3.7e-05	0.000115	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—PLBD1—lung cancer	3.67e-05	0.000334	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HSD17B10—lung cancer	3.65e-05	0.000333	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLBD1—lung cancer	3.64e-05	0.000331	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	3.6e-05	0.000328	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.58e-05	0.000326	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	3.55e-05	0.000323	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CKB—lung cancer	3.39e-05	0.000309	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HSD17B10—lung cancer	3.36e-05	0.000306	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HSD17B10—lung cancer	3.33e-05	0.000303	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM2—lung cancer	3.19e-05	0.000291	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CNDP2—lung cancer	3.19e-05	0.000291	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.17e-05	0.000288	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AZIN2—lung cancer	3.17e-05	0.000288	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ERCC2—lung cancer	3.13e-05	0.000285	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CKB—lung cancer	3.12e-05	0.000284	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTMR3—lung cancer	3.1e-05	0.000283	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CKB—lung cancer	3.09e-05	0.000282	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PGAM1—lung cancer	3.03e-05	0.000276	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM2—lung cancer	2.94e-05	0.000267	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CNDP2—lung cancer	2.94e-05	0.000267	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM2—lung cancer	2.91e-05	0.000265	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CNDP2—lung cancer	2.91e-05	0.000265	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2A7—lung cancer	2.89e-05	0.000263	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTMR3—lung cancer	2.86e-05	0.00026	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTMR3—lung cancer	2.83e-05	0.000258	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SDC4—lung cancer	2.82e-05	0.000257	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—lung cancer	2.82e-05	0.000257	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PGAM1—lung cancer	2.78e-05	0.000253	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PGAM1—lung cancer	2.76e-05	0.000251	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ATP5H—lung cancer	2.69e-05	0.000245	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—POMC—lung cancer	2.68e-05	0.000245	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2A7—lung cancer	2.65e-05	0.000242	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2A7—lung cancer	2.63e-05	0.00024	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SDC4—lung cancer	2.6e-05	0.000237	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SDC4—lung cancer	2.58e-05	0.000235	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA3—lung cancer	2.57e-05	0.000234	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—RRM1—lung cancer	2.57e-05	0.000234	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—B4GALT5—lung cancer	2.42e-05	0.00022	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLBD1—lung cancer	2.4e-05	0.000219	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—RRM1—lung cancer	2.37e-05	0.000215	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA3—lung cancer	2.37e-05	0.000215	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA4—lung cancer	2.35e-05	0.000214	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—RRM1—lung cancer	2.35e-05	0.000214	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA3—lung cancer	2.35e-05	0.000214	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.3e-05	0.000209	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA2—lung cancer	2.29e-05	0.000209	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CREBBP—lung cancer	2.29e-05	0.000209	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—B4GALT5—lung cancer	2.22e-05	0.000203	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA1—lung cancer	2.21e-05	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—B4GALT5—lung cancer	2.21e-05	0.000201	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSD17B10—lung cancer	2.2e-05	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCC3—lung cancer	2.19e-05	0.000199	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA4—lung cancer	2.16e-05	0.000197	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA4—lung cancer	2.15e-05	0.000195	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKR1C1—lung cancer	2.12e-05	0.000193	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA2—lung cancer	2.11e-05	0.000192	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.1e-05	0.000191	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA2—lung cancer	2.09e-05	0.00019	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—UGT1A1—lung cancer	2.06e-05	0.000187	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CKB—lung cancer	2.04e-05	0.000186	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA1—lung cancer	2.03e-05	0.000185	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA1—lung cancer	2.02e-05	0.000184	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCC3—lung cancer	2.01e-05	0.000183	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCC3—lung cancer	1.99e-05	0.000182	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GNG11—lung cancer	1.98e-05	0.000181	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.97e-05	0.00018	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKR1C1—lung cancer	1.95e-05	0.000177	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKR1C1—lung cancer	1.93e-05	0.000176	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM2—lung cancer	1.92e-05	0.000175	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CNDP2—lung cancer	1.92e-05	0.000175	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—UGT1A1—lung cancer	1.89e-05	0.000172	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDOA—lung cancer	1.89e-05	0.000172	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—UGT1A1—lung cancer	1.88e-05	0.000171	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTMR3—lung cancer	1.87e-05	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOA3—lung cancer	1.83e-05	0.000167	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GNG11—lung cancer	1.82e-05	0.000166	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PGAM1—lung cancer	1.82e-05	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GNG11—lung cancer	1.81e-05	0.000165	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.8e-05	0.000164	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.8e-05	0.000164	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG2—lung cancer	1.78e-05	0.000162	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADCY1—lung cancer	1.78e-05	0.000162	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ENO2—lung cancer	1.75e-05	0.000159	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HPGDS—lung cancer	1.75e-05	0.000159	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.74e-05	0.000158	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDOA—lung cancer	1.74e-05	0.000158	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2A7—lung cancer	1.74e-05	0.000158	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDOA—lung cancer	1.72e-05	0.000157	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.71e-05	0.000156	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SDC4—lung cancer	1.7e-05	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTT1—lung cancer	1.7e-05	0.000154	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOA3—lung cancer	1.69e-05	0.000154	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2A6—lung cancer	1.68e-05	0.000153	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GCLC—lung cancer	1.68e-05	0.000153	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOA3—lung cancer	1.67e-05	0.000152	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.67e-05	0.000152	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.64e-05	0.00015	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADCY1—lung cancer	1.64e-05	0.000149	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG2—lung cancer	1.64e-05	0.000149	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADCY1—lung cancer	1.63e-05	0.000148	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG2—lung cancer	1.63e-05	0.000148	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ENO2—lung cancer	1.61e-05	0.000146	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HPGDS—lung cancer	1.61e-05	0.000146	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.6e-05	0.000146	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HPGDS—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ENO2—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ENO1—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.58e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.58e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.56e-05	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.56e-05	0.000142	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTT1—lung cancer	1.56e-05	0.000142	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—RRM1—lung cancer	1.55e-05	0.000141	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA3—lung cancer	1.55e-05	0.000141	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTT1—lung cancer	1.55e-05	0.000141	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GCLC—lung cancer	1.54e-05	0.00014	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2A6—lung cancer	1.54e-05	0.00014	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GCLC—lung cancer	1.53e-05	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2A6—lung cancer	1.53e-05	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.52e-05	0.000139	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ENO1—lung cancer	1.46e-05	0.000133	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—B4GALT5—lung cancer	1.45e-05	0.000132	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ENO1—lung cancer	1.45e-05	0.000132	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.44e-05	0.000131	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2E1—lung cancer	1.43e-05	0.00013	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.43e-05	0.00013	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA4—lung cancer	1.41e-05	0.000129	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NQO1—lung cancer	1.41e-05	0.000128	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK3—lung cancer	1.4e-05	0.000127	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.38e-05	0.000126	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA2—lung cancer	1.38e-05	0.000126	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.37e-05	0.000125	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—lung cancer	1.36e-05	0.000124	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA1—lung cancer	1.33e-05	0.000121	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCC3—lung cancer	1.32e-05	0.00012	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2E1—lung cancer	1.31e-05	0.000119	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2E1—lung cancer	1.3e-05	0.000118	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NQO1—lung cancer	1.3e-05	0.000118	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NQO1—lung cancer	1.29e-05	0.000117	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKR1C1—lung cancer	1.27e-05	0.000116	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—STK11—lung cancer	1.27e-05	0.000116	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.25e-05	0.000114	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UGT1A1—lung cancer	1.24e-05	0.000113	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.19e-05	0.000109	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GNG11—lung cancer	1.19e-05	0.000109	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—lung cancer	1.18e-05	0.000107	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—STK11—lung cancer	1.17e-05	0.000106	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—STK11—lung cancer	1.16e-05	0.000106	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAT—lung cancer	1.14e-05	0.000104	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.14e-05	0.000104	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDOA—lung cancer	1.14e-05	0.000103	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—lung cancer	1.11e-05	0.000101	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOA3—lung cancer	1.1e-05	0.0001	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TYMS—lung cancer	1.09e-05	9.95e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.09e-05	9.9e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—lung cancer	1.08e-05	9.85e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—lung cancer	1.08e-05	9.84e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADCY1—lung cancer	1.07e-05	9.76e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG2—lung cancer	1.07e-05	9.76e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—lung cancer	1.07e-05	9.76e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAT—lung cancer	1.05e-05	9.58e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HPGDS—lung cancer	1.05e-05	9.58e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENO2—lung cancer	1.05e-05	9.58e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.04e-05	9.52e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAT—lung cancer	1.04e-05	9.5e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.04e-05	9.44e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1A1—lung cancer	1.02e-05	9.33e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—lung cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTT1—lung cancer	1.02e-05	9.29e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ERCC2—lung cancer	1.02e-05	9.25e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—lung cancer	1.01e-05	9.24e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.01e-05	9.18e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCLC—lung cancer	1.01e-05	9.18e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TYMS—lung cancer	1.01e-05	9.15e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TYMS—lung cancer	9.96e-06	9.08e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—lung cancer	9.94e-06	9.05e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—lung cancer	9.85e-06	8.97e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENO1—lung cancer	9.56e-06	8.7e-05	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—lung cancer	9.43e-06	8.59e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1A1—lung cancer	9.42e-06	8.58e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ERCC2—lung cancer	9.34e-06	8.51e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1A1—lung cancer	9.34e-06	8.5e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ERCC2—lung cancer	9.26e-06	8.43e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOA1—lung cancer	8.79e-06	8e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2E1—lung cancer	8.57e-06	7.81e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NQO1—lung cancer	8.48e-06	7.72e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.41e-06	7.66e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOA1—lung cancer	8.08e-06	7.36e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—lung cancer	8.02e-06	7.31e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOA1—lung cancer	8.01e-06	7.3e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.67e-06	6.99e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—STK11—lung cancer	7.64e-06	6.96e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—POMC—lung cancer	7.64e-06	6.95e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CREBBP—lung cancer	7.44e-06	6.77e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—lung cancer	7.38e-06	6.72e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—lung cancer	7.31e-06	6.66e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—lung cancer	7.07e-06	6.44e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CD—lung cancer	7.05e-06	6.42e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—POMC—lung cancer	7.02e-06	6.4e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—POMC—lung cancer	6.96e-06	6.34e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—lung cancer	6.96e-06	6.34e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAT—lung cancer	6.88e-06	6.26e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CREBBP—lung cancer	6.84e-06	6.23e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CREBBP—lung cancer	6.78e-06	6.18e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—lung cancer	6.69e-06	6.09e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TYMS—lung cancer	6.57e-06	5.99e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—lung cancer	6.5e-06	5.92e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CD—lung cancer	6.49e-06	5.91e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CD—lung cancer	6.43e-06	5.86e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—lung cancer	6.4e-06	5.83e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—lung cancer	6.35e-06	5.78e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1A1—lung cancer	6.16e-06	5.61e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CB—lung cancer	6.15e-06	5.6e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ERCC2—lung cancer	6.11e-06	5.56e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—lung cancer	6.09e-06	5.55e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CB—lung cancer	5.65e-06	5.15e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CB—lung cancer	5.6e-06	5.1e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—lung cancer	5.6e-06	5.1e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—lung cancer	5.55e-06	5.06e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—lung cancer	5.31e-06	4.84e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOA1—lung cancer	5.28e-06	4.81e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—EP300—lung cancer	5.06e-06	4.61e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—lung cancer	4.88e-06	4.45e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—lung cancer	4.84e-06	4.41e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—lung cancer	4.82e-06	4.39e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—EP300—lung cancer	4.66e-06	4.24e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—EP300—lung cancer	4.62e-06	4.21e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—POMC—lung cancer	4.59e-06	4.18e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CREBBP—lung cancer	4.47e-06	4.07e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CD—lung cancer	4.24e-06	3.86e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—lung cancer	4.19e-06	3.81e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—lung cancer	3.75e-06	3.41e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CB—lung cancer	3.7e-06	3.37e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—lung cancer	3.66e-06	3.34e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—lung cancer	3.45e-06	3.14e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—lung cancer	3.42e-06	3.11e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—lung cancer	3.19e-06	2.91e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—lung cancer	3.06e-06	2.79e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—EP300—lung cancer	3.05e-06	2.77e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—lung cancer	2.82e-06	2.56e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—lung cancer	2.79e-06	2.54e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—lung cancer	2.25e-06	2.05e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
